Terry-Ann Burrell's Net Worth
$16 Million
Who is Terry-Ann Burrell?
Terry-Ann Burrell has an estimated net worth of $16 Million. This is based on reported shares across multiple companies, which include Beam Therapeutics Inc., and RECURSION PHARMACEUTICALS, INC..
SEC CIK
Terry-Ann Burrell's CIK is 0001786484
Past Insider Trading and Trends
2021 was Terry-Ann Burrell's most active year for acquiring shares with 13 total transactions. Terry-Ann Burrell's most active month to acquire stocks was the month of December. 2021 was Terry-Ann Burrell's most active year for disposing of shares, totalling 23 transactions. Terry-Ann Burrell's most active month to dispose stocks was the month of December. 2024 saw Terry-Ann Burrell paying a total of $1,342,000.00 for 55,000 shares, this is the most they've acquired in one year. In 2021 Terry-Ann Burrell cashed out on 749,999 shares for a total of $10,550,501.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Beam Therapeutics Inc. (BEAM) Snapshot price: $27.66
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.82% | 12.5K |
—
|
—
| 82.64K |
Apr 26
| |||
Form 4
| -7.21% | -5.45K |
$32.12 | -$174,925.52 | 70.14K |
Apr 1
| |||
Form 4
| +57.19% | 27.5K |
—
|
—
| 75.58K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| -8.96% | -4.64K |
$29.74 | -$137,978.26 | 47.12K |
Apr 3 - Apr 4
| |||
Form 4
| +63.94% | 20K |
—
|
—
| 51.28K |
Jan 31 - Mar 31
| |||
Form 4
|
—
|
0
|
$29.38 | -$1,169,875.14 | 31.28K |
Scheduled
|
Jan 26 - Jan 27
| ||
Form 4
|
—
|
0
|
$29.35 | -$634,118.77 | 31.28K |
Scheduled
|
Jan 23 - Jan 24
| ||
Form 4
| -18.94% | -7.31K |
$29.41 | -$1,584,741.82 | 31.28K |
Scheduled
|
Jan 18
| ||
Form 4
| +52.71% | 13.21K |
$59.11 | -$105,629.57 | 38.28K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
$67.84 | -$3,249,600.00 | 24.81K |
Scheduled
|
Jun 30
| ||
Form 4
|
—
|
0
|
$60.69 | -$4,230,416.46 | 24.81K |
Scheduled
|
Jun 28
| ||
Form 4
| +239.43% | 17.5K |
—
|
—
| 24.81K |
Mar 31
| |||
Form 4
|
—
|
0
|
$47.73 | -$1,702,484.79 | 7.31K |
Scheduled
|
Jan 4
| ||
Form 4
|
∞
| 7.31K |
$13.68 | $99,987.12 | 7.31K |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RECURSION PHARMACEUTICALS, INC. (RXRX) Snapshot price: $9.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.67% | 1.47K |
—
|
—
| 56.31K |
Apr 1
| |||
Form 4
| -68.08% | -117.00K |
$12.07 | -$1,412,413.53 | 54.85K |
Jul 12 - Jul 13
| |||
Form 4
| +7.92% | 12.61K |
—
|
—
| 171.85K |
Jun 16
| |||
Form 4
| +1.16% | 1.82K |
—
|
—
| 159.24K |
Jan 3
| |||
Form 4
| +0.81% | 1.26K |
—
|
—
| 157.41K |
Oct 3
| |||
Form 4
| +1.06% | 1.63K |
—
|
—
| 156.15K |
Jul 1
| |||
Form 4
| +13.31% | 18.14K |
—
|
—
| 154.52K |
Jun 14
| |||
Form 4
| +1.33% | 1.79K |
—
|
—
| 136.37K |
Apr 1
| |||
Form 4
| +0.57% | 763 |
—
|
—
| 134.59K |
Jan 3
| |||
Form 4
| +0.47% | 629 |
—
|
—
| 133.82K |
Oct 1
| |||
Form 4
| +0.29% | 382 |
—
|
—
| 133.19K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
| 132.81K |
Apr 20
| |||
Form 4
| +5.19% | 6.25K |
—
|
—
| 126.56K |
Apr 15 - Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||